News & Insights

Subscribe

  • People
  • Offices
    • back
    • Offices
    • North America
      • back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Dallas
      • Denver
      • Houston
      • Los Angeles
      • Miami
      • New York
      • Northern Virginia
      • Sacramento
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle East
      • back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Paris
      • Riyadh
    • Asia
      • back
      • Asia
      • Singapore
      • Tokyo
  • Capabilities
    • back
    • Capabilities
    • Corporate, Finance and Investments
      • back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Fund Finance
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Leveraged Finance
      • Mergers and Acquisitions (M&A)
      • Middle East and Islamic Finance and Investment
      • Private Equity
      • Public Companies
      • Real Estate
      • Structured Finance and Securitization
      • Tax
      • Technology Transactions
    • Government Matters
      • back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • Innovation Protection
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global Disputes
      • back
      • Trial and Global Disputes
      • Overview
      • Antitrust
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Construction and Engineering Disputes
      • Corporate and Securities Litigation
      • E-Discovery
      • Innovation Protection
      • Intellectual Property
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / Issues
      • back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy Transition
      • Energy
      • Financial Services
      • Food and Beverage
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • Artificial Intelligence (AI) and Machine Learning
      • Buy American
      • Crisis Management
      • Doing Business in Latin America
      • Environmental Agenda
      • Environmental, Social and Governance (ESG)
      • Focus on Women's Health
      • Russia/Ukraine
      • Special Purpose Acquisition Companies (SPACs)
  • Careers
    • back
    • Careers
    • Lawyers
      • back
      • Lawyers
      • Experienced Lawyers
    • Students
      • back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial Clerks
      • back
      • Judicial Clerks
      • Judicial Clerks
    • Business Professionals
      • back
      • Business Professionals
      • Business Professionals
  • News & Insights
    • back
    • News & Insights
    • News
      • back
      • News
      • All News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • Events
      • back
      • Events
      • All Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • Insights
      • back
      • Insights
      • All Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • Auditor Liability Bulletin
      • ESG Excellence
  • About
    • back
    • About
    • Our Firm
      • back
      • Our Firm
      • History
      • Our Values
    • Our Culture
      • back
      • Our Culture
      • Overview
    • Citizenship
      • back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

News & Insights

  • News
    • back
    • News
    • All News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • Events
    • back
    • Events
    • All Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • Insights
    • back
    • Insights
    • All Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • Auditor Liability Bulletin
    • ESG Excellence
< Back to Bio
Nikki Reeves
Calendar view

Events 28 results

Webinar

April 29, 2025
FCA Enforcement and Litigation: How Recent Decisions and Policy Announcements Signal Key Changes

Webinar

January 29, 2025
Summary of FDA’s New Final Guidance: Scientific Information on Unapproved Uses

Webinar

January 22, 2025
Year in Review for Drug and Device Advertising and Promotion

Speaking Engagement

January 6, 2025
Nikki Reeves to Speak at Inaugural Episode of FDAWatch

Conference

November 12, 2024
Pharmaceutical University 2024

Speaking Engagement

October 8, 2024
Nikki Reeves and Gillian Russell to Speak at the Seton Hall Compliance Congress

Webinar

September 18, 2024
Addressing Misinformation: Insights on Social Media and Influencer Marketing

Conference

September 5, 2024
17th Annual King & Spalding Medical Device Summit

Conference

May 15, 2024
Annual King & Spalding California Life Sciences Summit

Speaking Engagement

January 23, 2024
Nikki Reeves to Speak at ACI’s Advanced Legal, Regulatory and Compliance Forum on OTC Drugs

Webinar

January 17, 2024
Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2023 FDA Enforcement Letters and Other Key Developments

Webinar

December 11, 2023
#Sponsored: Influencer Marketing 201 for Pharmaceutical and Medical Device Companies

© 2025 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Transparency Disclosure
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • Fraud Notice
  • Lawyers Alumni Group